Encouraging patients to play a greater role in their own health care can contribute to better care outcomes and better health. To that end, AMSURG is unveiling a flexible patient engagement platform with significant growth potential that relies on a patient’s own clinical data to drive participation and compliance.
A recent pilot of the program asked whether providing expanded clinical information at the time of recall, such as findings from a previous screening colonoscopy, along with an enhanced patient experience produces a substantially improved patient recall success rate. The answer, overwhelmingly, was yes.
The participating centers and practices were already running the full spectrum of patient recall programs with existing recall levels ranging from zero to 25%. After implementing the Patient Engagement platform, AMSURG was able to increase the recall rate at all participating centers to approximately 40%.
“Patients are more engaged in their own healthc are decisions than ever before,” said Kathy Wilson, vice president, clinical quality. “And given the massive amount of healthcare cost attributed to behavioral choices, this is an area where we can make a big impact.”
The initial stage of this program interfaces with GIQuIC data and focuses on GI patient recall, but the long-term benefit of this program lies in its flexibility. In the future, AMSURG can expand the program to work with any clinical data in any specialty.
“We do not have 100% uniformity at our centers in terms of EHRs or other patient management systems, so it was crucial to build a program that was as flexible as possible,” said Rich Palumbo, vice president, marketing. With this approach, centers and practices can interact with the program and its capabilities in a way that recognizes and accommodates existing processes, and physicians can rest easy knowing that encryption technologies are protecting health information at every point of data transmission.
“The exciting potential of this solution is that we will be able to provide our partners with tools that will not be available, or easily replicated, by their competing groups. Not only will this give our partners a competitive advantage, but it will help us in our ongoing aims to better serve our patients and drive down colon cancer mortality rates,” said Robert Goldstein, associate vice president, patient contact solutions.
For more information about partnering with AMSURG, contact us.